Women

Pregnancy-Lipid Effect & ASCVD Risk Management

Lipid Management from Pre-conception to Pregnancy through Lactation

The Lipid Panel – Polycystic Ovary Syndrome

The Lipid Panel – Women’s Heart Health

Dyslipidemia Management in Women of Reproductive Potential

The Effects of Testosterone Therapy in Females on Lipid Parameters and Cardiovascular Disease Risk

In a systematic review and meta-analysis of 29 trials with moderate risk of bias, Maraka S. et al summarized the…

The Lipid Panel – A Woman’s Heart – HT Effects on Lipids, CVD, etc.

Practical Pearls – Lipids in Women in Reproductive Years

S2E6: Women’s Cardiovascular Health

Dr. Alan Brown sits down with Zareen Farukhi, MD, MPH, Associate Physician at Brigham and Women’s Hospital and Instructor at…

Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association

Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association

Lipid Management in Pregnancy and Lactation

Normal pregnancy is characterized by physiologic increases in maternal levels of cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein…

When Is It Reasonable to Consider Withholding Lipid Lowering Therapy?

Lipid lowering therapy is a cornerstone of cardiovascular risk reduction. However, withholding or stopping lipid lowering therapy may be worth…

Finding Familial Hypercholesterolemia in the Perinatal Period

Familial hypercholesterolemia (FH) is an autosomal codominant genetic disorder of lipoprotein metabolism associated with disproportionately high levels of lowdensity lipoprotein…

Women’s Health: Guidelines for Lipid-Lowering in Women – What Have we Learned?

Cardiovascular disease (CVD) remains the leading cause of death for women in the United States.(1) Unique factors affecting a woman’s…

Management of Hypercholesterolemia in Young Women of Childbearing Years and During Pregnancy

JK is a 35-year-old female nonsmoker who first presented to clinical lipidology care after developing angina while breastfeeding her first…

Severe Hypertriglyceridemia in a 40-Year-Old Woman: Using the ApoB App to Confirm a Diagnosis and Target Future Cardiovascular Risk

Case History Mary is a 40-year-old school teacher who was referred for severe elevation of triglycerides (TGs). She has a…

Conventional and Non-Conventional Treatment Options for Post-Menopausal Symptoms

Up to 80 percent of post-menopausal women suffer from a variety of symptoms related to decreased estrogen. The most common…

Hormone Replacement Therapy and Cardiovascular Risk

Hormone replacement therapy (HRT) in post-menopausal women has been a topic of constant debate. HRT with conjugated equine estrogens (CEE)…

Statins for Primary Prevention in Women: How an Individual-Benefit Model Could Expand Treatment to Hypercholesterolemic Women Under Age 65 with 10-Year ASCVD Risk Less Than 7.5%

Evidence in support of statins for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in women was sparse until recently.1 …

Current Understanding of the Contribution of Lipoprotein(a) to Atherosclerotic Cardiovascular Disease Risk in Women

It is well-established that, compared to men, post-menopausal women enjoy a degree of protection against atherosclerotic cardiovascular disease (ASCVD).1  The…

Evaluation of Women for the Primary Prevention of Atherosclerotic Cardiovascular Disease

The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic…

The Important Role of Lipidologists in Dispelling ASCVD Treatment Myths Among Special Populations

A 52-year-old woman was referred to our Lipid Clinic several weeks ago by her primary care physician who felt overwhelmed…